Quantcast

Latest Enantiopure drugs Stories

2014-08-30 12:20:58

-- LCZ696 mortality benefit exceeded what was achieved with enalapril, an ACE-inhibitor, when replacing enalapril combined with current treatment regimen for HF-REF1 -- Study showed significantly more HF-REF patients on LCZ696 regimen were alive and had fewer hospitalizations than those given enalapril regimen1 -- Heart failure affects more than 600,000 Canadians18 and is responsible for 9 per...

2014-08-30 08:20:58

- Study showed significantly more HF-REF patients on LCZ696 regimen were alive, had fewer hospitalizations than those given enalapril regimen(1) EAST HANOVER, N.J., Aug. 30, 2014 /PRNewswire/ -- Today at the European Society of Cardiology congress and published simultaneously in the New England Journal of Medicine, Novartis revealed that its investigational heart failure medicine, LCZ696, was superior to ACE-inhibitor enalapril on key endpoints in the largest heart failure study ever...

2014-08-11 00:20:49

-- LCZ696 significantly reduced cardiovascular deaths in head to head study against enalapril, in addition to current best treatment, in patients with HF-REF EAST HANOVER, N.J., Aug. 11, 2014 /PRNewswire/ -- New data revealing the reduction in cardiovascular (CV) deaths with Novartis' LCZ696 in patients with heart failure with reduced ejection fraction (HF-REF) will be presented at the world's largest cardiology congress, the European Society of Cardiology (ESC) Congress 2014, on Sunday...

2014-08-06 23:11:18

The DrugNews Center is the web’s largest source for prescription drug warnings, research and legal news. Visit http://www.DrugNews.net today. New York, NY (PRWEB) August 06, 2014 The birth control resource center at DrugNews.net is alerting women who have taken the oral contraceptives Yaz or Yasmin of new information on the site. A recent report shows the maker of the drugs has settled approximately 8,900 cases alleging they caused side effects*. DrugNews is a free online resource...

2014-07-23 23:13:00

The DrugNews Center is the web’s largest source for prescription drug warnings, research and legal news. Visit http://www.DrugNews.net today. Chicago, IL (PRWEB) July 23, 2014 The birth control resource center at DrugNews.net is alerting women who have taken the oral contraceptives Yaz or Yasmin of new information on the site. A federal panel recently released updated records showing more than 8,500 cases still pending alleging side effects from the drugs*. DrugNews is a free online...

2014-06-25 04:20:59

LEXINGTON, Massachusetts, June 25, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announces that Judge Stanley R. Chesler of the U.S. District Court for the District of New Jersey granted Shire's summary judgment motion in a patent infringement lawsuit, holding that certain claims of the patents protecting Vyvanse(R) (lisdexamfetamine dimesylate) were both infringed and valid. The ruling prevents the five pharmaceutical manufacturers (the ANDA Defendants) who...

2014-06-24 23:02:48

The DrugNews Center is the web’s largest source for prescription drug warnings, research and legal news. Visit http://www.DrugNews.net today. Chicago, IL (PRWEB) June 24, 2014 The birth control safety advocates at DrugNews.net are alerting women who have taken the oral contraceptives Yaz or Yasmin of new litigation news on the site. Recent court records show there are still nearly 9,000 lawsuits pending that allege side effects from the drugs*. DrugNews was created for patients taking...

2014-06-17 23:12:52

The DrugNews Center is the web’s largest source for prescription drug warnings, research and legal news. Visit http://www.DrugNews.net today. Chicago, IL (PRWEB) June 17, 2014 The birth control safety advocates at DrugNews.net are alerting women who have taken the oral contraceptives Yaz or Yasmin of new information on the site. The latest court records show a drop in the number of new lawsuits alleging side effects from the drug*, while the number of Yaz settlements has risen**....

2014-05-15 12:36:52

Carbapenems Are Increasingly Being Deployed as Frontline Therapies, According to Findings from Decision Resources Group BURLINGTON, Mass., May 15, 2014 /PRNewswire/ -- Decision Resources Group finds that the majority of surveyed hospital-based infectious disease and critical/intensive care specialists in the EU5 (France, Germany, Italy, Spain and the United Kingdom) reported increases in infection rates due to key drug-resistant Gram-negative pathogens (GNPs) over the past two years. Further,...

2014-04-30 16:30:05

ALISO VIEJO, Calif., April 30, 2014, 2014 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that the U.S. District Court for the District of Delaware has ruled in favor of Avanir in the company's patent infringement lawsuit against Par Pharmaceuticals, Inc. and Impax Laboratories, Inc. in conjunction with their Abbreviated New Drug Applications ('ANDAs') for generic versions of NUEDEXTA® (dextromethorphan hydrobromide/quinidine sulfate) capsules for the...


Word of the Day
blee
  • Color; hue; complexion.
This word is Middle English in origin.
Related